Ticker
NMTCCompany Name
NEUROONE MEDICAL TECHNOLOGIES CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -4.97M | -51.56% | $ 9.63M |
3/31/2025 | $ -6.24M | -71.19% | $ 8.76M |
12/31/2024 | $ -6.82M | -77.97% | $ 8.75M |
9/30/2024 | $ -11.96M | -346.3% | $ 3.45M |
6/30/2024 | $ -11.74M | -299.36% | $ 3.92M |
3/31/2024 | $ -12.45M | -334.1% | $ 3.73M |
12/31/2023 | $ -13.14M | -466.62% | $ 2.82M |
9/30/2023 | $ -11.55M | -338.96% | $ 3.41M |
6/30/2023 | $ -9.82M | -209.94% | $ 4.68M |
3/31/2023 | $ -9.14M | -223.97% | $ 4.08M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for NEUROONE MEDICAL TECHNOLOGIES CORP is calculated as follows: EBITDA [ $ -6.05M ] / Revenues [ $ 1.93M ]
(=) EBITDA % [ -313.77% ]
Minimum
Jun 30, 2022
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.29K |
---|---|
min | -74.33% |
max | 97.24% |
average | 16.2% |
median | 14.74% |
std | 26.73% |